Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3R,5S dihydroxy compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120230725A reveals high-selectivity monooxygenase mutants for statin synthesis. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.